Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

Blood

Volumn 102, Issue 8, 2003, Pages 2951-2959

  Ross, Mary E ^b   Zhou, Xiaodong ^b   Song, Guangchun ^b   Shurtleff, Sheila A ^b   Girtman, Kevin ^b   Williams, W Kent ^b   Liu, Hsi Che ^b   Mahfouz, Rami ^b   Raimondi, Susana C ^b   Lenny, Noel ^b   Patel, Anami ^b   Downing, James R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; KARYOTYPE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA;

EID: 0141993002     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0338     Document Type: Article

References (38)

1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605-615.
2. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia-current status and future perspectives. Lancet Oncol. 2001;2:597-607.
3. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood. 2000;95:3310-3322.
4. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97:1211-1218.
5. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 2000;14:2286-2294.
6. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia. 2000;14:2276-2285.
7. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14:18-24.
8. Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist. 2000;5:321-328.
9. Sather HN. Age at diagnosis in childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1986;14:166-172.
10. Sallan SE, Ritz J, Pesando J, et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. Blood. 1980;55:395-402.
11. Ferrando AA, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol. 2000;37:381-395.
12. Downing JR, Shannon KM. Acute leukemia: a pediatric perspective. Cancer Cell. 2002;2:437-445.
13. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
14. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
15. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999-2009.
16. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133-143.
17. Fayyad UM, Irani KB. Multi-interval discretization of continuous-valued attributes. In: Proceedings 19th International Joint Conference on Artificial Intelligence. San Mateo, CA: Morgan Kaufman; 1993:1022-1027.
18. Witten H, Frank E. Data Mining: Practical Machine Learning Tools and Techniques with Java Implementation. San Mateo, CA: Morgan Kaufman; 2000.
19. Platt J. Fast training of support vector machines using sequential minimal optimization. In: Schlkopf B, Burges C, Smola A, eds. Advances in Kemel Methods - Support Vector Leaming. Cambridge, MA: MIT Press; 1999:105-208.
20. Cover TM, Hart PE. Nearest neighbor pattern classification. IEEE Trans Information Theory. 1967;13:21-27.
21. Li J, Liu H, Downing JR, Yeoh E-J, Wong L. Simple rules underlying gene expression profiles of more than six subtypes of acute lymphoblastic leukemia (ALL) patients. Bioinformatics. 2003;19:71-78.
22. Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the 1(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene. 1999;18:4920-4929.
23. McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A. 1999;96:11464-11469.
24. Fullwood Y, dos Santos M, Hsuan JJ. Cloning and characterization of a novel human phosphatidylinositol transfer protein, rdgBbeta. J Biol Chem. 1999;274:31553-31558.
25. Horvat S, Medrano JF. Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics. 2001;72:209-212.
26. Irminger-Finger I, Leung WC. BRCA1-dependent and independent functions of BARD1. Int J Biochem Cell Biol. 2002;34:582-587.
27. Whittock NV, Hunt DM, Rickman L, et al. Genomic organization and amplification of the human desmosomal cadherin genes DSC1 and DSC3, encoding desmocollin types 1 and 3. Biochem Biophys Res Commun. 2000;276:454-460.
28. Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 2001;276:3238-3246.
29. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30:41-47.
30. Schoch C, Kohlmann A, Schnittger S, et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A. 2002;99:10008-10013.
31. Moos PJ, Raetz EA, Carlson MA, et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res. 2002;8:3118-3130.
32. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993;81:2237-2251.
33. Harrison CJ, Martineau M, Secker-Walker LM. The leukaemia research fund/United Kingdom Cancer Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol. 2001;113:3-10.
34. van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901-1928.
35. Martinez-Climent JA, Thirman MJ, Espinosa R III, Le Beau MM, Rowley JD. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. Leukemia. 1995;9:1299-1304.
36. Cuthbert G, Thompson K, Breese G, McCullough S, Bown N. Sensitivity of FISH in detection of MLL translocations. Genes Chromosomes Cancer. 2000;29:180-185.
37. Andersson A, Hoglund M, Johansson B, et al. Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies. Leukemia. 2001;15:1293-1300.
38. Advani AS, Pendergast AM. Bcr-Abl variants: biological and clinical aspects. Leuk Res. 2002;26:713-720.